145 related articles for article (PubMed ID: 33184010)
1. Cytologically targeted next-generation sequencing: a synergy for diagnosing urothelial carcinoma.
Harris T; Sheel A; Zong Y; Hutchinson LM; Cornejo KM; Bubendorf L; Yates J; Fischer AH
J Am Soc Cytopathol; 2021; 10(1):94-102. PubMed ID: 33184010
[TBL] [Abstract][Full Text] [Related]
2. Urinary tract cytology: a cytologic-histopathologic correlation with The Paris System, an institutional study.
Danakas A; Sweeney M; Cheris S; Agrawal T
J Am Soc Cytopathol; 2021; 10(1):56-63. PubMed ID: 33132054
[TBL] [Abstract][Full Text] [Related]
3. High-grade urothelial carcinoma with hypochromatic chromatin in urine cytology.
Renshaw AA; Gould EW
J Am Soc Cytopathol; 2021; 10(1):25-28. PubMed ID: 33132055
[TBL] [Abstract][Full Text] [Related]
4. A review of urinary cytology in the setting of upper tract urothelial carcinoma.
Zhang ML; VandenBussche CJ; Hang JF; Miki Y; McIntire PJ; Peyton S; Vohra P
J Am Soc Cytopathol; 2021; 10(1):29-35. PubMed ID: 32792229
[TBL] [Abstract][Full Text] [Related]
5. Foreword: JASC urine cytology special edition.
Wojcik EM; Pambuccian SE; Rosenthal DL
J Am Soc Cytopathol; 2021; 10(1):1-2. PubMed ID: 33168474
[No Abstract] [Full Text] [Related]
6. An institutional experience evaluating hTERT immunostaining in 100 consecutive ThinPrep urine specimens.
Xing J; Han M; Monaco SE; Dhir R; Roy S; Pantanowitz L
J Am Soc Cytopathol; 2021; 10(1):88-93. PubMed ID: 32354607
[TBL] [Abstract][Full Text] [Related]
7. Developing a Machine Learning Algorithm for Identifying Abnormal Urothelial Cells: A Feasibility Study.
Zhang Z; Fu X; Liu J; Huang Z; Liu N; Fang F; Rao J
Acta Cytol; 2021; 65(4):335-341. PubMed ID: 33022673
[TBL] [Abstract][Full Text] [Related]
8. Targeted education as a method for reinforcing Paris System criteria and reducing urine cytology atypia rates.
Compton ML; Weiss VL; Barkan GA; Ely KA
J Am Soc Cytopathol; 2021; 10(1):9-13. PubMed ID: 32771394
[TBL] [Abstract][Full Text] [Related]
9. Experience on the use of The Paris System for Reporting Urinary Cytopathology: review of the published literature.
Pastorello RG; Barkan GA; Saieg M
J Am Soc Cytopathol; 2021; 10(1):79-87. PubMed ID: 33160893
[TBL] [Abstract][Full Text] [Related]
10. The Paris System for reporting urinary cytology in daily practice with emphasis on ancillary testing by multiprobe FISH.
Vlajnic T; Gut A; Savic S; Bubendorf L
J Clin Pathol; 2020 Feb; 73(2):90-95. PubMed ID: 31467041
[TBL] [Abstract][Full Text] [Related]
11. Causes of false-negative for high-grade urothelial carcinoma in urine cytology.
Lee PJ; Owens CL; Lithgow MY; Jiang Z; Fischer AH
Diagn Cytopathol; 2016 Dec; 44(12):994-999. PubMed ID: 27781412
[TBL] [Abstract][Full Text] [Related]
12. The Paris System "atypical urothelial cells" category: can the current criteria be improved?
Vosoughi A; Ordobazari A; Lora Gonzalez MA; Guido LP; Skiba M; Campuzano-Zuluaga G; Kryvenko ON; Gomez-Fernandez C; Garcia-Buitrago M; Jorda M
J Am Soc Cytopathol; 2021; 10(1):3-8. PubMed ID: 32732113
[TBL] [Abstract][Full Text] [Related]
13. The Paris System for Reporting Urinary Cytology reduces atypia rates and does not alter the negative predictive value of urine cytology.
McIntire PJ; Kilic I; Pambuccian SE; Wojcik EM; Barkan GA
J Am Soc Cytopathol; 2021; 10(1):14-19. PubMed ID: 33221245
[TBL] [Abstract][Full Text] [Related]
14. The diagnostic value of cytohistological urine analysis and cytokeratin 20 in malignant and atypical urothelial cells.
Negri S; Biavati P; Bondi A
Pathologica; 2016 Sep; 108(3):130-135. PubMed ID: 28195264
[TBL] [Abstract][Full Text] [Related]
15. Cyto-histo correlations of plasmacytoid and micropapillary variants of high-grade urothelial carcinoma: do they fit well in The Paris System for reporting urinary cytology?
Suo L; Vega I; Thrall M
J Am Soc Cytopathol; 2021; 10(1):20-24. PubMed ID: 32620533
[TBL] [Abstract][Full Text] [Related]
16. Evidence-based diagnostic accuracy measurement in urine cytology using likelihood ratios.
Myles N; Auger M; Kanber Y; Caglar D; Kassouf W; Brimo F
J Am Soc Cytopathol; 2021; 10(1):71-78. PubMed ID: 33071190
[TBL] [Abstract][Full Text] [Related]
17. The clinical significance of class III (suspicious) urine cytology.
Sternberg I; Rona R; Olsfanger S; Lew S; Leibovitch I
Cytopathology; 2011 Oct; 22(5):329-33. PubMed ID: 21114557
[TBL] [Abstract][Full Text] [Related]
18. A new 7-point method facilitates accurate diagnosis of high-grade urothelial carcinoma in routine urinary cytology practice.
Iwai S; Mimura A; Ohtani H; Shimokama T; Kinjo M
J Am Soc Cytopathol; 2021; 10(1):103-109. PubMed ID: 33092994
[TBL] [Abstract][Full Text] [Related]
19. High-grade urothelial carcinoma in urine cytology: different spaces - different faces, highlighting morphologic variance.
McIntire PJ; Elsoukkary SS; Robinson BD; Siddiqui MT
J Am Soc Cytopathol; 2021; 10(1):36-40. PubMed ID: 32958411
[TBL] [Abstract][Full Text] [Related]
20. Outcome analysis and negative predictive value of the "unsatisfactory/nondiagnostic" category of The Paris System for Reporting Urinary Cytology.
Abro S; Nomani L; Wojcik EM; Pambuccian SE; Chatt G; Barkan GA
J Am Soc Cytopathol; 2021; 10(1):64-70. PubMed ID: 33279453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
